HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Optimum dosage of an oral contraceptive. A report from the study of seven combinations of norgestimate and ethinyl estradiol.

Abstract
A statistically designed study was carried out to determine an optimum combination of norgestimate and ethinyl estradiol as an oral contraceptive, based on efficacy, safety, and side-effect patterns. A total of 1,991 patients were studied for more than two years while they were receiving various dosage combinations of these steroids. There were seven dosage combinations studied as part of a statistically orthogonal experimental design, augmented by three combinations near the center. The data arising from these studies were used to fit approximate functions relating the amount of norgestimate and ethinyl estradiol to the rate of spotting and breakthrough bleeding, gastrointestinal disturbance, and pregnancies. These functions, in turn, helped to identify an optimum dosage (0.125 mg. of norgestimate plus 0.035 mg. of ethinyl estradiol) in the entire range of combinations studied.
AuthorsJ S Lawson, S E Yuliano, S A Pasquale, J J Osterman
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 134 Issue 3 Pg. 315-20 (Jun 01 1979) ISSN: 0002-9378 [Print] United States
PMID377968 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Contraceptives, Oral
  • Contraceptives, Oral, Combined
  • Contraceptives, Oral, Hormonal
  • Norgestrel
  • Ethinyl Estradiol
  • norgestimate
Topics
  • Adolescent
  • Adult
  • Clinical Trials as Topic
  • Contraceptives, Oral (administration & dosage)
  • Contraceptives, Oral, Combined (administration & dosage, adverse effects)
  • Contraceptives, Oral, Hormonal (administration & dosage)
  • Double-Blind Method
  • Drug Evaluation
  • Ethinyl Estradiol (administration & dosage, adverse effects)
  • Female
  • Gastrointestinal Diseases (chemically induced)
  • Humans
  • Norgestrel (administration & dosage, adverse effects, analogs & derivatives)
  • Pregnancy
  • Random Allocation
  • Uterine Hemorrhage

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: